1. Home
  2. TRDA vs LZM Comparison

TRDA vs LZM Comparison

Compare TRDA & LZM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRDA
  • LZM
  • Stock Information
  • Founded
  • TRDA 2016
  • LZM 2021
  • Country
  • TRDA United States
  • LZM Isle of Man
  • Employees
  • TRDA N/A
  • LZM N/A
  • Industry
  • TRDA Biotechnology: Pharmaceutical Preparations
  • LZM Metal Mining
  • Sector
  • TRDA Health Care
  • LZM Basic Materials
  • Exchange
  • TRDA Nasdaq
  • LZM Nasdaq
  • Market Cap
  • TRDA 609.7M
  • LZM 563.7M
  • IPO Year
  • TRDA 2021
  • LZM N/A
  • Fundamental
  • Price
  • TRDA $18.70
  • LZM $7.08
  • Analyst Decision
  • TRDA Strong Buy
  • LZM Strong Buy
  • Analyst Count
  • TRDA 3
  • LZM 2
  • Target Price
  • TRDA $23.33
  • LZM $12.50
  • AVG Volume (30 Days)
  • TRDA 105.0K
  • LZM 87.9K
  • Earning Date
  • TRDA 11-05-2024
  • LZM 12-24-2024
  • Dividend Yield
  • TRDA N/A
  • LZM N/A
  • EPS Growth
  • TRDA N/A
  • LZM N/A
  • EPS
  • TRDA 1.55
  • LZM N/A
  • Revenue
  • TRDA $215,232,000.00
  • LZM $1,020,728.00
  • Revenue This Year
  • TRDA $47.45
  • LZM N/A
  • Revenue Next Year
  • TRDA N/A
  • LZM $890.00
  • P/E Ratio
  • TRDA $11.61
  • LZM N/A
  • Revenue Growth
  • TRDA 146.92
  • LZM N/A
  • 52 Week Low
  • TRDA $11.35
  • LZM $4.52
  • 52 Week High
  • TRDA $21.79
  • LZM $9.97
  • Technical
  • Relative Strength Index (RSI)
  • TRDA 48.30
  • LZM 52.97
  • Support Level
  • TRDA $17.26
  • LZM $6.93
  • Resistance Level
  • TRDA $21.79
  • LZM $7.29
  • Average True Range (ATR)
  • TRDA 0.88
  • LZM 0.32
  • MACD
  • TRDA -0.29
  • LZM 0.01
  • Stochastic Oscillator
  • TRDA 34.03
  • LZM 65.93

About TRDA Entrada Therapeutics Inc.

Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Its pipeline includes solutions for Neuromuscular Disease, Beyond Neuromuscular, and Platform Expansion.

About LZM Lifezone Metals Limited

Lifezone Metals Ltd seeks to support the clean energy transition through the licensing of Hydromet Technology as an alternative to smelting and metals refining and to become an emerging supplier of responsibly sourced, lower-carbon and lower-sulfur dioxide emission metals to the battery, EV, and hydrogen markets modern pre-development exploration-stage metals company. Its business comprises two segments: Metals extraction and refining for developing and operating a vertically integrated base metal operation in the northwest region of Tanzania and Intellectual property licensing comprises patents residing with and managed by the subsidiary.

Share on Social Networks: